4. Kruszewski SP, Klotz SG. Effects of topiramate. Am J Psychiatry 2007; 164: 526-7. 5.
McClellan JM. Olanzapine and pediatric bipolar disorder: evidence for efficacy and safety …

Two atypical antipsychotic drugs, risperidone and aripiprazole, are currently approved for
the treatment of these conditions in pediatric patients. But the FDA asked its advisors to …

STUDIES CONTINUE TO DOCUMENT worrisome trends in pediatric antipsychotic
prescribing, as evidence builds about the risks of substantial weight gain and emergent …

Pediatric bipolar disorder remains the focus of considerable debate. At the crux of the issue
is how to define the illness in youth, and whether the same medications approved for …

This is a comment on" An open clinical trial of buspirone in children with attention-
deficit/hyperactivity disorder." J Am Acad Child Adolesc Psychiatry. 1998 Apr; 37 (4): 364-71 …

A pair of recent research articles has cast the public spotlight on treating children and
adolescents with antipsychotic medications.(1, 2) In the first report, a large and broadly …

BACKGROUND AND OBJECTIVE: Despite increasing on-label and off-label use of
antipsychotics, prescribing antipsychotics to children remains controversial due to …

Abstract Weight Gain and Metabolic Effects Because neurotransmitters alter central satiety
and appetite mechanisms, weight gain is a common adverse effect of antipsychotic …

Objective To assess weight and metabolic effects of 6 months of treatment with second-
generation antipsychotics in naïve/quasi-naïve youths. Method This study looked at a …

The article provides update related to psychotropic medications in the US A US Food and
Drug Administration advisory panel has recommended extending the existing pediatric black …